Updates from Cytotheryx

Cytotheryx Secures City Council Sponsorship for Major Funding Application

We are thrilled to share that the Rochester City Council has approved sponsoring Cytotheryx for applications to the Minnesota Department of Employment and Economic Development for the Minnesota Investment Fund and the Minnesota Job Creation Fund. We are hoping to secure a total of $870,000 in funding to support expansion in Rochester to further our mission.

Read More »

Cytotheryx at the Startup Showcase Event

We are excited to share that Cytotheryx participated in the prestigious MN Ventures Startup Showcase. Launch Minnesota, in collaboration with the University of Minnesota, Medical Alley, and MNSBIR, Inc., hosted this exclusive gathering to spotlight innovative local startups and connect them with investors from across the country.

Read More »

Ponte Biosciences Wins Pitch Contest at Medtech MVP

We are thrilled to announce that Ponte Biosciences, a subsidiary of Cytotheryx, emerged as the grand prize winner at the inaugural Avio Medtech Consulting pitch competition during the 23rd Annual Medtech MVP event in Minneapolis. This recognition comes with a $20,000 non-dilutive funding award, a boost for our work in developing life-saving technology for patients with acute liver failure.

Read More »

Conference Connections

We’re proud to be part of the cell and gene therapy community, and to participate in conferences like Meeting on the Mesa where we can build partnerships.

Read More »

Litter Bit Better

The Cytotheryx team is committed to community volunteering. We’re proud to have spent time volunteering together to keep our city clean and beautiful.

Read More »
Covid statement

Covid-19 Statement

We are committed to our work and the wellness of our communities, and will remain so during this challenging and uncertain time of COVID-19.

Read More »